Mackenzie Financial
VSTM icon

Mackenzie Financial’s Verastem VSTM Stock Holding History

Mackenzie Financial’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,702
Closed -$29K – 1553
2022
Q1 		$29K Hold
1,702
– – ﹤0.01% 1385
2021
Q4 		$42K Sell
1,702
-45
-3% -$1.42K ﹤0.01% 1406
2021
Q3 		$65K Buy
+1,747
New +$64.2K ﹤0.01% 1400

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Mackenzie Financial's VSTM Position: Q2 2022 in Review

Mackenzie Financial sold out of Verastem (VSTM) in Q2 2022, closing a stake of 1,702 shares — an estimated $29K sold.

Mackenzie Financial first reported a position in VSTM in Q3 2021 and held it in 3 quarters. The position peaked at $65K in Q3 2021. 122 funds tracked by Wall St. Rank hold VSTM as of Q2 2022.

  • Mackenzie Financial reported no remaining Verastem position as of Q2 2022 after selling out during the quarter.
  • Mackenzie Financial sold 1,702 Verastem shares in Q2 2022, an estimated $29K.
  • Mackenzie Financial first reported a position in Verastem in Q3 2021 and held it in 3 quarters.
  • Mackenzie Financial's Verastem position peaked at $65K in Q3 2021.
  • 122 funds tracked by Wall St. Rank held Verastem as of Q2 2022.

Based on Mackenzie Financial's 13F filing for Q2 2022, filed 10 Aug 2022.